Fulgent Genetics, Inc.
FLGT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $558,440 | $861,055 | $896,289 | $2,958,151 |
| - Cash | $55,144 | $97,473 | $79,506 | $164,894 |
| + Debt | $9,226 | $15,251 | $20,638 | $21,284 |
| Enterprise Value | $512,522 | $778,833 | $837,421 | $2,814,541 |
| Revenue | $283,470 | $289,213 | $618,968 | $992,584 |
| % Growth | -2% | -53.3% | -37.6% | – |
| Gross Profit | $107,215 | $104,456 | $366,901 | $777,051 |
| % Margin | 37.8% | 36.1% | 59.3% | 78.3% |
| EBITDA | -$48,990 | -$147,454 | $217,700 | $686,957 |
| % Margin | -17.3% | -51% | 35.2% | 69.2% |
| Net Income | -$42,708 | -$167,825 | $143,403 | $507,364 |
| % Margin | -15.1% | -58% | 23.2% | 51.1% |
| EPS Diluted | -1.41 | -5.63 | 4.63 | 16.26 |
| % Growth | 75% | -221.6% | -71.5% | – |
| Operating Cash Flow | $21,060 | $27,003 | $253,520 | $538,577 |
| Capital Expenditures | -$40,315 | -$22,207 | -$18,775 | -$23,844 |
| Free Cash Flow | -$19,255 | $4,796 | $234,745 | $514,733 |